Skip to main content
Caplight Logo









Engine Biosciences

Engine Biosciences

Private
SingaporeHealthcare & Life Scienceshttps://www.enginebio.com/

Last Round

Series A

Extension

Oct 31, 2023

Est. Valuation

$82M

Total Funding Raised

$80M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Engine Biosciences is a biotechnology company that develops precision oncology medicines and biomarkers by integrating machine learning with high-throughput biology and combinatorial genetics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoveryfunctional genomicsprecision medicineAI drug discoveryCRISPR screeningin silico drug discoverybiotech platformtarget identificationbiomarker discoverycomputational biologyoncology researchgenetic interactionhigh-throughput screeningAI-native biotechdrug discovery pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Engine Biosciences Comparables

Compare Engine Biosciences with similar companies based on industry and business-model similarity.

Engine Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Waypoint Bio
88%
Relation Therapeutics
81%
Nucleome Therapeutics
80%

Engine Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 31, 2023
Series AMay 26, 2021
SeedJan 31, 2018

Key People

Founding team and executive leadership

Jeffrey Lu

Co-Founder and CEO

Founding Team

Engine Biosciences Investors

Notable investors and investment history

Engine Biosciences investors
InvestorRounds
Nest.BioSeries A, Seed
SEEDS CapitalSeries A Extension
Vectr VenturesSeries A
Camford CapitalSeries A, Seed
Baidu VenturesSeries A, Seed
WI Harper GroupSeries A, Seed
ClavystBioSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 137% MoM.

  • Jun 9, 2026

    Grew 16% QoQ, from 31 to 36 employees.

Engine Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Engine Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Engine Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range37
Year Founded2014
Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?